Ursprung des Netzwerks ersten Grades von Kenichi Kumagaya
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
MiRTeL Co. Ltd.
 MiRTeL Co. Ltd. Miscellaneous Commercial ServicesCommercial Services MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kenichi Kumagaya
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
The University of Tokyo Edge Capital Co. Ltd.
 The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Investment Managers | Private Equity Investor | |
Editforce, Inc.
 Editforce, Inc. Miscellaneous Commercial ServicesCommercial Services Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
bitBiome, Inc.
 bitBiome, Inc. Miscellaneous Commercial ServicesCommercial Services The Japanese company has a wealth of experience in micro-biome research and have obtained high-quality microbial genome data from various samples. The company is based in Tokyo, Japan. The company strategically combines their own single-cell analysis technology, bit-map®, to realize the next-generation microbiome analysis that approaches the essence of microbial functions. The company also uses the microbial genomic information owned by bitBiome to provide new knowledge for research and development promoted by joint partners and customers. The company was founded by Yoshihito Daimon, Masahito Hosokawa. Kimihiko Sato has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Japan | 4 |
Sektoral
| Commercial Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 6 |
| Private Equity Investor | 1 |
| President | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Atsushi Usami | 4 |
| Toshiya Kato | 1 |
| Naoki Tomogami | 1 |
| Mayu Yoshikawa | 1 |
- Börse
- Insiders
- Kenichi Kumagaya
- Unternehmensverbindungen
